Team led by NIIMBL is Selected for Gates Grand Challenge $10.5 Million Funding Award
Today, NIIMBL (the National Institute for Innovation in Manufacturing Biopharmaceuticals) announced that a NIIMBL-led team will receive $10.5 Million in funding through the Gates Grand Challenges Program to advance exceptionally low-cost monoclonal antibody (mAb) manufacturing. Over the three-year award, key partners including Sartorius, Rensselaer Polytechnic Institute, Enquyst Technologies, and the University of Delaware will demonstrate […]